Citigroup
AGN

Citigroup’s Allergan plc AGN Stock Holding History

Citigroup’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-140,200
Closed -$24.8M – 7843
2020
Q1 		$24.8M Sell
140,200
-20,900
-13% -$3.94M 0.02% 627
2019
Q4 		$30.8M Sell
161,100
-20,400
-11% -$3.68M 0.02% 738
2019
Q3 		$30.5M Buy
181,500
+32,100
+21% +$5.23M 0.02% 681
2019
Q2 		$25M Sell
149,400
-50,600
-25% -$7.01M 0.02% 809
2019
Q1 		$29.3M Buy
200,000
+26,300
+15% +$3.81M 0.03% 626
2018
Q4 		$23.2M Buy
173,700
+39,600
+30% +$6.49M 0.02% 737
2018
Q3 		$25.5M Sell
134,100
-83,400
-38% -$15.3M 0.02% 696
2018
Q2 		$36.3M Sell
217,500
-314,300
-59% -$50.5M 0.03% 479
2018
Q1 		$89.5M Buy
531,800
+233,300
+78% +$39.1M 0.07% 224
2017
Q4 		$48.8M Buy
298,500
+109,400
+58% +$19.6M 0.04% 437
2017
Q3 		$38.8M Sell
189,100
-39,400
-17% -$9.16M 0.03% 498
2017
Q2 		$55.5M Buy
228,500
+22,500
+11% +$5.29M 0.05% 318
2017
Q1 		$49.2M Sell
206,000
-400,604
-66% -$93.3M 0.04% 365
2016
Q4 		$127M Sell
606,604
-355,600
-37% -$73.7M 0.11% 150
2016
Q3 		$222M Sell
962,204
-147,900
-13% -$36.1M 0.21% 66
2016
Q2 		$257M Buy
1,110,104
+1,025,500
+1,212% +$236M 0.26% 55
2016
Q1 		$22.7M Sell
84,604
-181,699
-68% -$52M 0.03% 547
2015
Q4 		$83.2M Buy
266,303
+127,680
+92% +$38M 0.08% 218
2015
Q3 		$37.7M Buy
138,623
+18,764
+16% +$5.76M 0.04% 438
2015
Q2 		$36.4M Sell
119,859
-11,627
-9% -$3.47M 0.03% 497
2015
Q1 		$39.1M Sell
131,486
-68,654
-34% -$19.6M 0.04% 447
2014
Q4 		$51.5M Buy
200,140
+21,537
+12% +$5.38M 0.05% 392
2014
Q3 		$43.1M Buy
178,603
+4,503
+3% +$1.01M 0.04% 447
2014
Q2 		$38.5M Sell
174,100
-52,200
-23% -$10.8M 0.04% 449
2014
Q1 		$46.6M Buy
226,300
+155,600
+220% +$30.8M 0.05% 354
2013
Q4 		$11.9M Sell
70,700
-115,500
-62% -$18.1M 0.01% 1116
2013
Q3 		$26.8M Buy
186,200
+128,900
+225% +$17.2M 0.03% 591
2013
Q2 		$7.23M Buy
+57,300
New +$6.49M 0.01% 1333

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Citigroup's AGN Position: Q2 2020 in Review

Citigroup sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 7,925,753 shares — an estimated $1.4B sold.

Citigroup first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $1.4B in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Citigroup reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Citigroup sold 7,925,753 Allergan plc shares in Q2 2020, an estimated $1.4B.
  • Citigroup first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Citigroup's Allergan plc position peaked at $1.4B in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Citigroup's 13F filing for Q2 2020, filed 12 Aug 2020.